SCHEMBL13006291

SCHEMBL13006291

C#CC(O)c1ccc(OC)cc1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 2/20 0.39
ADRA1A P35348 2/20 0.39
GAA P10253 1/20 0.39
CYP2D6 P10635 1/20 0.38
MEN1 O00255 1/20 0.37
MAPK1 P28482 1/20 0.37
BLM P54132 1/20 0.37
KMT2A Q03164 1/20 0.37
HTT P42858 1/20 0.36
DHFR P00374 1/20 0.36
MAPT P10636 1/20 0.36
PTGS2 P35354 3/20 0.35
PTGS1 P23219 2/20 0.35
AKR1C3 P42330 2/20 0.35
AKR1C2 P52895 2/20 0.35
CDC42 P60953 1/20 0.35
RAC1 P63000 1/20 0.35
CYP1A2 P05177 1/20 0.35
TSHR P16473 1/20 0.35
SLC22A6 Q4U2R8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28690276 0.83 CA12 (0.47) ADRA2AADRA1ACYP2D6MEN1MAPK1
SCHEMBL6825547 0.80 ADRA2A (0.42) ADRA2AADRA1AGAACYP2D6MEN1
SCHEMBL12248178 0.78 ADRA2A (0.46) ADRA2AADRA1AGAACYP2D6MEN1
SCHEMBL31003156 0.78 ADRA2A (0.46) ADRA2AADRA1AGAACYP2D6MEN1
SCHEMBL8067912 0.78 TDP1 (0.40) ADRA1AMEN1KMT2AMAPTCYP1A2
SCHEMBL12248154 0.74 ADRA2A (0.47) ADRA2AADRA1AGAACYP2D6HTT
SCHEMBL21670853 0.74 SCN1A (0.41) ADRA2AADRA1AGAACYP2D6MEN1
SCHEMBL848282 0.74 KDM4E (0.49) GAACYP2D6MEN1KMT2AHTT
SCHEMBL9081255 0.73 ADRA2A (0.44) ADRA2AADRA1ACYP2D6MAPK1HTT
SCHEMBL10318373 0.72 HTT (0.46) BLMHTTPTGS2PTGS1AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851637-B2 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners INFINITY PHARMACEUTICALS, INC. (US) 2010-12-14 US disclosed
US-7851637-B2 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners INFINITY PHARMACEUTICALS, INC. (US) 2010-12-14 US disclosed